Pioglitazone-induced acute rhabdomyolysis
- PMID: 19564463
- PMCID: PMC2878484
- DOI: 10.2337/dc09-0593
Pioglitazone-induced acute rhabdomyolysis
Erratum in
- Diabetes Care. 2010 Jun;33(6):1406. Zami, Michele [corrected to Zamy, Michele]
References
-
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239– 245 - PubMed
-
- Kennie N, Antoniou T, Berger P: Elevated creatine kinase and myalgia in a patient taking rosiglitazone. Ann Pharmacother 2007; 41: 521– 524 - PubMed
-
- Yokoyama M, Izumiya Y, Yoshizawa M, Usuda R: Acute rhabdomyolysis associated with troglitazone. Diabetes Care 2000; 23: 421– 422 - PubMed
-
- Koro CE, Sowell MO, Stender M, Qizilbash N: The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Clin Ther 2008; 30: 535– 542 - PubMed
-
- Henney JE: New type 2 diabetes drugs. JAMA 1999; 282: 932. - PubMed